Accuracy of Pediatric Risk of Mortality (PRISM) III Score in Predicting Mortality Outcomes in a Pediatric Intensive

Sadiq Mirza1, Laraib Malik2, Jawad Ahmed3

  • 1Pediatric Critical Care, The Indus Hospital, Karachi, PAK.

Cureus
|May 6, 2020
PubMed

Insights

The Pediatric Risk of Mortality III (PRISM III) score accurately predicts mortality in pediatric intensive care units. This score helps identify critically ill children needing urgent care, especially in resource-limited settings.

Area of Science:

  • Pediatric Intensive Care
  • Clinical Epidemiology
  • Biostatistics

Background:

  • Pediatric intensive care units (PICUs) are crucial for managing critically ill children.
  • Accurate mortality prediction scales are vital for resource allocation and patient management.
  • Pediatric Risk of Mortality (PRISM) and Pediatric Index of Mortality (PIM) are commonly used predictive tools.

Purpose of the Study:

  • To evaluate the predictive accuracy of the Pediatric Risk of Mortality III (PRISM III) score in a tertiary care hospital's PICU.
  • To assess the correlation between PRISM III scores and patient mortality.
  • To determine the utility of PRISM III in resource-limited settings.

Main Methods:

  • A prospective hospital-based study conducted in a PICU from December 2017 to June 2019.
  • Inclusion of 407 patients aged one month to 12 years.
  • Calculation of PRISM III scores at 24 hours of admission using a standard questionnaire.

Main Results:

  • The overall mortality rate was 37.35% (152 out of 407 patients).
  • Factors associated with poor survival included mechanical ventilation, inotropic drug use, higher temperatures, and low Glasgow Coma Scale scores.
  • PRISM III demonstrated good predictive power with an Area Under the Curve of 0.903±0.016 (p<0.001).

Conclusions:

  • The PRISM III score exhibits excellent accuracy and predictive ability in the studied pediatric population.
  • Observed and expected mortality rates showed no significant difference, validating the score's performance.
  • PRISM III aids in identifying high-risk patients and assessing prognosis, crucial for resource allocation in underserved areas.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
130
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
703
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
208
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
148
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
170